Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis

Int J Mol Sci. 2022 Oct 20;23(20):12599. doi: 10.3390/ijms232012599.

Abstract

Oral microbiome changes take place at the initiation of rheumatoid arthritis (RA); however, questions remain regarding the oral microbiome at pre-RA stages in individuals with clinically suspect arthralgia (CSA). Two cross-sectional cohorts were selected including 84 Tatarstan women (15 early-RA as compared to individuals with CSA ranging from CSA = 0 [n = 22], CSA = 1 [n = 19], CSA = 2 [n = 11], and CSA ≥ 3 [n = 17]) and 42 women with established RA (median: 5 years from diagnosis [IQ: 2-11]). Amplicon sequence variants (ASVs) obtained from oral samples (16S rRNA) were analyzed for alpha and beta diversity along with the abundance at the genus level. A decrease in oral Porphyromonas sp. is observed in ACPA-positive individuals, and this predominates in early-RA patients as compared to non-RA individuals irrespective of their CSA score. In the RA-established cohort, Porphyromonas sp. and Aggregatibacter sp. reductions were associated with elevated ACPA levels. In contrast, no associations were reported when considering individual, genetic and clinical RA-associated factors. Oral microbiome changes related to the genera implicated in post-translational citrullination (Porphyromonas sp. and Aggregatibacter sp.) characterized RA patients with elevated ACPA levels, which supports that the role of ACPA in controlling the oral microbiome needs further evaluation.

Keywords: ACPA; Aggregatibacter sp.; Porphyromonas sp.; clinical suspect arthralgia; first degree relatives; oral microbiome; rheumatoid arthritis.

MeSH terms

  • Aggregatibacter
  • Anti-Citrullinated Protein Antibodies*
  • Arthralgia
  • Arthritis, Rheumatoid*
  • Autoantibodies
  • Cross-Sectional Studies
  • Female
  • Humans
  • Porphyromonas / genetics
  • RNA, Ribosomal, 16S / genetics
  • Rheumatoid Factor

Substances

  • Anti-Citrullinated Protein Antibodies
  • RNA, Ribosomal, 16S
  • Rheumatoid Factor
  • Autoantibodies